506 related articles for article (PubMed ID: 16859832)
21. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Tuynman JB; Peppelenbosch MP; Richel DJ
Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
[TBL] [Abstract][Full Text] [Related]
22. COX-2 inhibition in clinical cancer prevention.
Lynch PM
Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):21-6. PubMed ID: 11301836
[TBL] [Abstract][Full Text] [Related]
23. [Role of prostaglandins in colon cancer].
Myung SJ; Kim IH
Korean J Gastroenterol; 2008 May; 51(5):274-9. PubMed ID: 18516010
[TBL] [Abstract][Full Text] [Related]
24. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
Peek RM
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S50-6. PubMed ID: 15309515
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
Hilmi I; Goh KL
Chin J Dig Dis; 2006; 7(1):1-6. PubMed ID: 16412030
[TBL] [Abstract][Full Text] [Related]
26. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
Jiménez P; García A; Santander S; Piazuelo E
Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
[TBL] [Abstract][Full Text] [Related]
27. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
Vainio H; Morgan G
Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
Backlund MG; Mann JR; Dubois RN
Oncology; 2005; 69 Suppl 1():28-32. PubMed ID: 16210874
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
Arber N
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
[TBL] [Abstract][Full Text] [Related]
31. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
32. COX-2 and prostanoid receptors: good targets for chemoprevention.
Kawamori T; Wakabayashi K
J Environ Pathol Toxicol Oncol; 2002; 21(2):149-53. PubMed ID: 12086401
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.
Davies G; Martin LA; Sacks N; Dowsett M
Ann Oncol; 2002 May; 13(5):669-78. PubMed ID: 12075734
[TBL] [Abstract][Full Text] [Related]
35. NSAIDs and cancer prevention: targets downstream of COX-2.
Cha YI; DuBois RN
Annu Rev Med; 2007; 58():239-52. PubMed ID: 17100552
[TBL] [Abstract][Full Text] [Related]
36. Cyclo-oxygenase inhibition in colorectal adenomas and cancer.
Ricchi P; Pignata S; Iaffaioli RV; Daniele B
J Clin Gastroenterol; 2003 Oct; 37(4):281-7. PubMed ID: 14506383
[TBL] [Abstract][Full Text] [Related]
37. Potential role of selective COX-2 inhibitors in cancer management.
Dang CT; Shapiro CL; Hudis CA
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578
[TBL] [Abstract][Full Text] [Related]
38. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
Fajardo AM; Piazza GA
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in colorectal cancer prevention with cyclooxygenase inhibitors.
Ranger GS
Anticancer Res; 2014 Nov; 34(11):6277-82. PubMed ID: 25368225
[TBL] [Abstract][Full Text] [Related]
40. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
Cathcart MC; Lysaght J; Pidgeon GP
Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
